Your browser doesn't support javascript.
loading
High immunosuppressive burden in advanced hepatocellular carcinoma patients: Can effector functions be restored?
Lugade, Amit A; Kalathil, Suresh; Miller, Austin; Iyer, Renuka; Thanavala, Yasmin.
Afiliación
  • Lugade AA; Department of Immunology; Roswell Park Cancer Institute; Buffalo, NY USA.
Oncoimmunology ; 2(7): e24679, 2013 Jul 01.
Article en En | MEDLINE | ID: mdl-24073364
ABSTRACT
The accumulation of immunosuppressive cells and exhausted effector T cells highlight an important immune dysfunction in advanced stage hepatocellular carcinoma (HCC) patients. These cells significantly hamper the efficacy immunotherapies and facilitate HCC progression. We have recently demonstrated that the multipronged depletion of immunosuppressive cells potentially restores effector T-cell function in HCC.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncoimmunology Año: 2013 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncoimmunology Año: 2013 Tipo del documento: Article